Recurrent Hodgkin Lymphoma [clinicaltrials_resource:86c38c39793bc54cb1e1cdecb8de2a33]
Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [clinicaltrials:NCT00068718]Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT01028716]Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma [clinicaltrials:NCT01393717]Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma [clinicaltrials:NCT02378922]
condition [clinicaltrials_vocabulary:condition]
Recurrent Hodgkin Lymphoma [clinicaltrials_resource:86c38c39793bc54cb1e1cdecb8de2a33]
Bio2RDF identifier
86c38c39793bc54cb1e1cdecb8de2a33
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:86c38c39793bc54cb1e1cdecb8de2a33
identifier
clinicaltrials_resource:86c38c39793bc54cb1e1cdecb8de2a33
title
Recurrent Hodgkin Lymphoma
@en
label
Recurrent Hodgkin Lymphoma [clinicaltrials_resource:86c38c39793bc54cb1e1cdecb8de2a33]
@en